share_log

Intelligent Bio Solutions | 8-K: Current report

Intelligent Bio Solutions | 8-K: Current report

Intelligent Bio Solutions | 8-K:重大事件
美股sec公告 ·  04/09 08:34
Moomoo AI 已提取核心信息
Intelligent Bio Solutions Inc., a Delaware-incorporated company listed on The Nasdaq Stock Market under the trading symbol INBS, has filed a Form 8-K with the United States Securities and Exchange Commission on April 9, 2024. The filing includes a presentation related to the company's business and operations, which will be made available on the same day. This presentation is part of a Regulation FD disclosure and can be accessed through the Investors section of the company's website. Intelligent Bio Solutions has been identified as an emerging growth company and has furnished this information under Item 7.01 of the report, which is not to be considered 'filed' for purposes of the Exchange Act nor incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, unless specifically stated. The company's Chief Financial Officer, Spiro Sakiris, has signed off on the report.
Intelligent Bio Solutions Inc., a Delaware-incorporated company listed on The Nasdaq Stock Market under the trading symbol INBS, has filed a Form 8-K with the United States Securities and Exchange Commission on April 9, 2024. The filing includes a presentation related to the company's business and operations, which will be made available on the same day. This presentation is part of a Regulation FD disclosure and can be accessed through the Investors section of the company's website. Intelligent Bio Solutions has been identified as an emerging growth company and has furnished this information under Item 7.01 of the report, which is not to be considered 'filed' for purposes of the Exchange Act nor incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, unless specifically stated. The company's Chief Financial Officer, Spiro Sakiris, has signed off on the report.
Intelligent Bio Solutions Inc. 是一家在纳斯达克股票市场上市的特拉华州注册公司,交易代码为INBS,已于2024年4月9日向美国证券交易委员会提交了8-K表格。该文件包括与公司业务和运营相关的陈述,该陈述将在同一天公布。本演示文稿是定期存款披露的一部分,可通过公司网站的 “投资者” 部分进行访问。Intelligent Bio Solutions已被确定为新兴成长型公司,并已根据报告第7.01项提供了这些信息,除非特别说明,否则就交易法而言,该信息不应被视为 “已提交”,也不得以引用方式纳入根据1933年《交易法》或《证券法》提交的任何文件中。该公司首席财务官斯皮罗·萨基里斯已经签署了该报告。
Intelligent Bio Solutions Inc. 是一家在纳斯达克股票市场上市的特拉华州注册公司,交易代码为INBS,已于2024年4月9日向美国证券交易委员会提交了8-K表格。该文件包括与公司业务和运营相关的陈述,该陈述将在同一天公布。本演示文稿是定期存款披露的一部分,可通过公司网站的 “投资者” 部分进行访问。Intelligent Bio Solutions已被确定为新兴成长型公司,并已根据报告第7.01项提供了这些信息,除非特别说明,否则就交易法而言,该信息不应被视为 “已提交”,也不得以引用方式纳入根据1933年《交易法》或《证券法》提交的任何文件中。该公司首席财务官斯皮罗·萨基里斯已经签署了该报告。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息